CCMW
AGN

Cypress Capital Management (Wyoming)’s Allergan plc AGN Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-95
Closed – – 262
2016
Q1 		$0 Hold
95
– – ﹤0.01% 243
2015
Q4 		$29.7K Hold
95
– – 0.04% 132
2015
Q3 		$25.8K Buy
+95
New +$29.2K 0.03% 139

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s AGN Position: Q2 2016 in Review

Cypress Capital Management (Wyoming) sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 95 shares.

Cypress Capital Management (Wyoming) first reported a position in AGN in Q3 2015 and held it in 3 quarters. The position peaked at $29.7K in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Cypress Capital Management (Wyoming) reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 95 Allergan plc shares in Q2 2016.
  • Cypress Capital Management (Wyoming) first reported a position in Allergan plc in Q3 2015 and held it in 3 quarters.
  • Cypress Capital Management (Wyoming)'s Allergan plc position peaked at $29.7K in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2016, filed 28 Jul 2016.